Torrent Pharma Q4 Results: Firm back in the black with PAT of Rs 287 cr; board okays Rs 5000 crore fund raise
Revenue rose 17% year-on-year (YoY) to Rs 2491 crore in Q4FY23. The company said the performance was led by robust growth across branded markets including India and Brazil, Torrent said its board has approved a fund raise exceeding Rs 5,000 crores.
